Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000132

Chairperson & CEO sold 9,500 shares at an average $511.09 ($4,855,312)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-31 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-08-31 Sale : show line 2 in the form 10b5-1 −599 $507.84 $304,198 333,344 I
2026-08-31 Sale : show line 3 in the form 10b5-1 −794 $508.92 $404,082 332,550 I
2026-08-31 Sale : show line 4 in the form 10b5-1 −810 $509.84 $412,967 331,740 I
2026-08-31 Sale : show line 5 in the form 10b5-1 −4,217 $510.93 $2,154,598 327,523 I
2026-08-31 Sale : show line 6 in the form 10b5-1 −1,600 $511.75 $818,801 325,923 I
2026-08-31 Sale : show line 7 in the form 10b5-1 −678 $513.50 $348,154 325,245 I
2026-08-31 Sale : show line 8 in the form 10b5-1 −762 $514.32 $391,913 324,483 I
2026-08-31 Sale : show line 9 in the form 10b5-1 −40 $514.96 $20,598 324,443 I
Open-market sales · 9,500 sh · avg $511.09 · $4,855,312

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-31 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 27,910 I
Loading xslF345X06/primarydocument.xml…